Pharmaceutical, Drugs, Medicine, Biology, FDA.
challenges in the process. Unknown pathophysiology: Many nervous system disorders have poorly understood underlying pathophysiology, which can make target identification challenging. Without a clear understanding of the biological mechanisms driving the disease, it can be difficult to develop drugs